Rockwell Medical (RMTI) Revenue (QoQ) (2010 - 2026)
Rockwell Medical (RMTI) Revenue (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 26.80 Mn | 2.91 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.51% |
| Dec 31, 2025 | 15.19% |
| Sep 30, 2025 | -0.90% |
| Jun 30, 2025 | -15.03% |
| Mar 31, 2025 | -23.32% |
| Dec 31, 2024 | -12.89% |
| Sep 30, 2024 | 9.62% |
| Jun 30, 2024 | 13.92% |
| Mar 31, 2024 | 2.64% |
| Dec 31, 2023 | -7.06% |
| Sep 30, 2023 | 31.48% |
| Jun 30, 2023 | -8.07% |
| Mar 31, 2023 | 1.84% |
| Dec 31, 2022 | 3.33% |
| Sep 30, 2022 | 0.05% |
| Jun 30, 2022 | 15.86% |
| Mar 31, 2022 | 5.17% |
| Dec 31, 2021 | -4.10% |
| Sep 30, 2021 | 5.62% |
| Jun 30, 2021 | -2.17% |